2021
DOI: 10.3390/molecules26113266
|View full text |Cite
|
Sign up to set email alerts
|

NMR Profiling of Ononis diffusa Identifies Cytotoxic Compounds against Cetuximab-Resistant Colon Cancer Cell Lines

Abstract: In the search of new natural products to be explored as possible anticancer drugs, two plant species, namely Ononis diffusa and Ononis variegata, were screened against colorectal cancer cell lines. The cytotoxic activity of the crude extracts was tested on a panel of colon cancer cell models including cetuximab-sensitive (Caco-2, GEO, SW48), intrinsic (HT-29 and HCT-116), and acquired (GEO-CR, SW48-CR) cetuximab-resistant cell lines. Ononis diffusa showed remarkable cytotoxic activity, especially on the cetuxi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 32 publications
1
1
0
Order By: Relevance
“…Cetuximab, an antibody inhibiting the EGFR signaling pathway, is employed in the treatment of colorectal cancer [45]. While SW48 and CaCO2 colorectal cancer cells exhibit sensitivity to cetuximab, HT29 cancer cells display resistance [46]. Our cytotoxicity studies with benzoic acid yielded similar findings to cetuximab.…”
Section: Discussionsupporting
confidence: 64%
“…Cetuximab, an antibody inhibiting the EGFR signaling pathway, is employed in the treatment of colorectal cancer [45]. While SW48 and CaCO2 colorectal cancer cells exhibit sensitivity to cetuximab, HT29 cancer cells display resistance [46]. Our cytotoxicity studies with benzoic acid yielded similar findings to cetuximab.…”
Section: Discussionsupporting
confidence: 64%
“…Graziani et al employed NMR-based chemical profiling of Ononius diffusa to identify cytotoxic compounds with activity against colorectal cancer cell lines. This approach was found to be much more successful, in terms of time and costs in the detection and identification of bioactive compounds, as compared to classical bioactivity-guided fractionation [ 7 ]. A similar design, integrating chemical profiling with bioactivity tests, allowed Nipun et al [ 8 ] to identify α-glucosidase inhibitors from Psychotria malayana leaves using an LC-MS platform [ 8 ].…”
mentioning
confidence: 99%